Tuning siRNA packing order in lipid nanoparticles modulates oligonucleotide functional delivery
This study demonstrates that tuning lipid nanoparticle composition to favor less compact, low-order siRNA packing enhances endosomal fusion and cargo release, thereby significantly improving the functional delivery and silencing potency of siRNA therapeutics.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine a delivery service that must drop a fragile package inside a locked building. The package contains a set of instructions meant to shut down a specific machine inside. If the delivery vehicle is too sturdy, it might crash through the door but fail to open the package. If it is too fragile, it might fall apart before reaching the door. For years, scientists developing lipid nanoparticles—tiny, fat-based spheres used to carry genetic medicine like siRNA into cells—have focused on the vehicle's outer shell. They have tweaked the chemical ingredients to make the sphere stable in the bloodstream and able to fuse with cell membranes. Yet, despite these successes, a major bottleneck remains: most of the genetic cargo never escapes the cell's internal holding chambers to reach its target. The question has been why some delivery vehicles work while others, looking nearly identical from the outside, fail completely.
A team of researchers at the University of Copenhagen has looked inside these vehicles to find the answer. Instead of measuring the average properties of billions of particles at once, they developed a way to watch individual particles one by one. They labeled the fat shells and the genetic cargo inside with different glowing dyes, allowing them to see the size of each sphere and count exactly how many pieces of genetic material it carried. By imaging hundreds of thousands of these particles, they discovered that the internal arrangement of the cargo is not random. The particles fall into two distinct groups based on how tightly the genetic material is packed inside. One group has the cargo organized in neat, layered stacks, while the other group has the cargo in a loose, disordered, and amorphous clump.
The researchers found that this internal order dictates whether the medicine works. Counterintuitively, the particles with the neatly stacked, highly organized cargo were largely ineffective. Even though they carried a lot of genetic material, that material remained trapped and could not be released to do its job. In contrast, the particles with the loose, disordered packing were far more successful at silencing their target genes. These "low-order" particles carried less cargo on average, but they released what they had much more efficiently once inside the cell. The study showed that the key to unlocking the delivery was not just the chemical recipe of the fat shell, but the physical state of the cargo inside. By adjusting the ratio of positive to negative charges during the manufacturing process, the team could shift the balance between these two states. When they tuned the process to favor the loose, disordered packing, the therapeutic effect increased significantly.
This work suggests that the long-held assumption that more cargo equals better delivery is incorrect. The researchers demonstrated that a tightly packed, highly ordered structure acts as a barrier, preventing the genetic instructions from escaping the cell's internal traps. The loose, disordered structure, however, appears to be more responsive to the acidic environment inside the cell, allowing the cargo to spill out at the right moment. The team validated this by testing different formulations in living cells. They observed that cells treated with formulations containing the disordered particles showed a clear reduction in the target protein, while those treated with formulations consisting purely of highly ordered particles showed no measurable knockdown, despite taking up similar amounts of the delivery vehicle.
The study also clarified that the size of the particle does not predict how much cargo it holds or how well it works. Two particles of the same size could carry vastly different amounts of genetic material, and a particle with a lot of cargo might still fail to deliver it. The researchers used advanced microscopy to map these variations, revealing that the internal architecture is a distinct, measurable property that can be controlled. They showed that by changing the balance of ingredients, specifically the ratio of the lipid components to the genetic cargo, they could program the particle to adopt the loose, functional state. This finding offers a new way to design these medicines, moving beyond trial-and-error with chemical recipes to a more precise control over the physical structure of the delivery vehicle.
The implications are practical and immediate for the development of RNA therapeutics. The researchers established that the "low-order" state is the one that leads to successful gene silencing. They proved that this state is not a rare accident but a reproducible outcome that can be favored by adjusting the manufacturing conditions. The study ruled out the idea that simply increasing the amount of cargo or changing the outer shell ingredients is enough; the internal packing must be right. While the team noted that these findings need to be tested in more complex living systems, the method they developed provides a clear, quantitative way to see inside the particles and optimize them. The path forward is no longer about guessing which chemical mix works best, but about tuning the internal disorder to ensure the genetic message gets delivered.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.